BioXcel Therapeutics, Inc.

Analysis for Ticker: BTAI

BioXcel Therapeutics Inc uses an artificial intelligence platform called EvolverAI to find new uses for old drugs in the fields of neuroscience and cancer. But the reality is a financial machine that spent 69,9$ million in 2025 just to generate 642.000$ in sales. It is like one bakery that spends seventy dollars on electricity and flour just to sell one cookie for sixty cents. The math is a disaster because the company survives by printing free pieces of itself for its leaders while borrowing millions of dollars at high interest rates that it cannot pay back.